Sun Pharma Q2 results: Consolidated net profit rises 13% to Rs 2,047 crore

Pharma giant Sun Pharmaceutical Industries on Tuesday reported 13 per cent rise in Profit After Tax (PAT), beating expectation of the street. The drugmaker Sun Pharmaceutical posted a 13 per cent rise in consolidated net profit to Rs 2,047 crore on year-on-year (YoY) basis. The PAT stood at Rs 1,813 crore in the same quarter in 2020.  

See Zee Business Live TV Streaming Below:

The pharma company had reported a profit of Rs 1,444 crore in the quarter ended June 2021.

Meanwhile, the consolidated revenue from operations rose to Rs 9,625.9 crore, a 12.5 per cent on year-on-year.